Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
acetylcholinesterase | 9 | 0 | 0 | 9 |
pregnane X receptor | 6 | 0 | 0 | 6 |
SMAD family member 2 | 8 | 0 | 0 | 8 |
SMAD family member 3 | 8 | 0 | 0 | 8 |
TDP1 protein | 25 | 0 | 0 | 25 |
GLI family zinc finger 3 | 19 | 0 | 0 | 19 |
Microtubule-associated protein tau | 15 | 0 | 0 | 15 |
AR protein | 31 | 0 | 0 | 31 |
progesterone receptor | 14 | 0 | 0 | 14 |
glucocorticoid receptor [Homo sapiens] | 24 | 0 | 0 | 24 |
retinoic acid nuclear receptor alpha variant 1 | 21 | 0 | 0 | 21 |
retinoid X nuclear receptor alpha | 17 | 0 | 0 | 17 |
estrogen-related nuclear receptor alpha | 20 | 0 | 0 | 20 |
farnesoid X nuclear receptor | 17 | 0 | 0 | 17 |
pregnane X nuclear receptor | 18 | 0 | 0 | 18 |
estrogen nuclear receptor alpha | 30 | 0 | 0 | 30 |
G | 11 | 0 | 0 | 11 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
arylsulfatase A | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 20 | 0 | 0 | 20 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 15 | 0 | 0 | 15 |
activating transcription factor 6 | 11 | 0 | 0 | 11 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 21 | 0 | 0 | 21 |
geminin | 20 | 0 | 0 | 20 |
survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
Voltage-dependent calcium channel gamma-2 subunit | 17 | 0 | 0 | 17 |
Interferon beta | 12 | 0 | 0 | 12 |
HLA class I histocompatibility antigen, B alpha chain | 11 | 0 | 0 | 11 |
Glucocorticoid receptor | 1 | 12 | 4 | 19 |
Sex hormone-binding globulin | 0 | 0 | 4 | 4 |
Glycine receptor subunit alpha-1 | 0 | 12 | 0 | 12 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 13 | 0 | 13 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 13 | 0 | 13 |
Alpha-1B adrenergic receptor | 0 | 15 | 0 | 15 |
Glutamate receptor 2 | 17 | 0 | 0 | 17 |
Glycine receptor subunit beta | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-2 | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-3 | 0 | 12 | 0 | 12 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 15 | 0 | 15 |
Sodium-dependent dopamine transporter | 0 | 10 | 0 | 10 |
TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
Inositol hexakisphosphate kinase 1 | 11 | 0 | 0 | 11 |
cytochrome P450 2C9, partial | 11 | 0 | 0 | 11 |
ATP-dependent phosphofructokinase | 9 | 0 | 0 | 9 |
RAR-related orphan receptor gamma | 17 | 0 | 0 | 17 |
ATAD5 protein, partial | 11 | 0 | 0 | 11 |
GLS protein | 8 | 0 | 0 | 8 |
Smad3 | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 17 | 0 | 0 | 17 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
nuclear receptor subfamily 1, group I, member 3 | 17 | 0 | 0 | 17 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
peroxisome proliferator activated receptor gamma | 17 | 0 | 0 | 17 |
aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 20 | 0 | 0 | 20 |
peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit pi | 8 | 4 | 1 | 13 |
ATP-binding cassette sub-family C member 3 | 0 | 18 | 0 | 18 |
Multidrug resistance-associated protein 4 | 0 | 18 | 0 | 22 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 12 | 0 | 3 | 0 | 4 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 26 | 0 | 26 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 8 | 0 | 9 |
Carbonic anhydrase 2 | 0 | 8 | 1 | 10 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 3 |
Cytochrome P450 3A4 | 0 | 9 | 1 | 10 |
Cytochrome P450 2D6 | 0 | 5 | 0 | 5 |
Cytochrome P450 2C9 | 0 | 4 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 4 | 1 | 13 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 4 | 1 | 13 |
UDP-glucuronosyltransferase 1-6 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 4 | 1 | 13 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 4 | 0 | 6 |
Carbonic anhydrase 4 | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 9 |
Carbonic anhydrase 6 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 4 | 1 | 13 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 4 |
Nuclear receptor ROR-gamma | 8 | 0 | 0 | 8 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 5 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 4 | 1 | 13 |
Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 4 | 1 | 13 |
Carbonic anhydrase 9 | 0 | 4 | 0 | 5 |
GABA theta subunit | 8 | 4 | 1 | 13 |
Canalicular multispecific organic anion transporter 1 | 0 | 17 | 0 | 17 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 8 | 4 | 1 | 13 |
Carbonic anhydrase 14 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 4 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 12 | 0 | 0 | 12 |
thioredoxin reductase | 10 | 0 | 0 | 10 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 6 | 0 | 0 | 6 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 8 | 0 | 0 | 8 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
ATP-dependent translocase ABCB1 | 0 | 8 | 1 | 10 |
Mu-type opioid receptor | 0 | 5 | 1 | 6 |
Kappa-type opioid receptor | 0 | 3 | 0 | 4 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Cellular tumor antigen p53 | 22 | 0 | 0 | 22 |
Thromboxane-A synthase | 0 | 4 | 0 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostacyclin receptor | 0 | 4 | 2 | 6 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 5 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 14 | 0 | 0 | 14 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 8 | 0 | 0 | 8 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 7 | 0 | 0 | 7 |
Chain B, HADH2 protein | 7 | 0 | 0 | 7 |
Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 7 | 0 | 0 | 7 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 14 | 0 | 0 | 14 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 12 | 0 | 0 | 12 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 11 | 0 | 0 | 11 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
DNA polymerase kappa isoform 1 | 5 | 0 | 0 | 5 |
muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
lethal factor (plasmid) | 6 | 0 | 0 | 6 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Epidermal growth factor receptor | 0 | 4 | 0 | 4 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Integrin beta-3 | 4 | 1 | 0 | 5 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 4 | 1 | 0 | 5 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 4 | 1 | 6 |
Adenosine receptor A2a | 0 | 4 | 1 | 7 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 8 | 1 | 9 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
Fumarate hydratase | 6 | 0 | 0 | 6 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
polyprotein | 6 | 0 | 0 | 6 |
P53 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
Histone H2A.x | 9 | 0 | 0 | 9 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
heat shock protein beta-1 | 10 | 0 | 0 | 10 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
Ataxin-2 | 10 | 0 | 0 | 10 |
Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
Genome polyprotein | 0 | 1 | 1 | 2 |
dopamine D1 receptor | 3 | 0 | 0 | 3 |
regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
vitamin D3 receptor isoform VDRA | 12 | 0 | 0 | 12 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 14 | 0 | 14 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
Beta-1 adrenergic receptor | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 14 | 0 | 14 |
D(2) dopamine receptor | 0 | 13 | 1 | 14 |
Alpha-2B adrenergic receptor | 0 | 16 | 0 | 16 |
Alpha-2C adrenergic receptor | 0 | 8 | 0 | 8 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 12 | 1 | 13 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 4 | 1 | 5 |
D(1A) dopamine receptor | 0 | 10 | 0 | 10 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 14 | 1 | 15 |
5-hydroxytryptamine receptor 2C | 0 | 14 | 1 | 15 |
5-hydroxytryptamine receptor 1B | 0 | 10 | 0 | 10 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 15 | 0 | 15 |
Alpha-synuclein | 6 | 3 | 0 | 9 |
5-hydroxytryptamine receptor 2B | 0 | 16 | 0 | 16 |
5-hydroxytryptamine receptor 6 | 0 | 12 | 0 | 12 |
D(2) dopamine receptor | 0 | 3 | 1 | 4 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
DNA polymerase beta | 5 | 0 | 0 | 5 |
nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 8 | 1 | 10 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 5 | 1 | 8 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 4 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 2 |
BlaVIM-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
USP1 protein, partial | 10 | 0 | 0 | 10 |
caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 13 | 0 | 0 | 13 |
67.9K protein | 8 | 0 | 0 | 8 |
caspase-3 | 4 | 0 | 0 | 4 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 7 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 4 |
Delta-type opioid receptor | 0 | 4 | 0 | 4 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 13 | 3 | 16 |
Delta-type opioid receptor | 0 | 9 | 0 | 9 |
Kappa-type opioid receptor | 0 | 13 | 0 | 13 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 7 | 0 | 7 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Estrogen receptor | 1 | 12 | 6 | 20 |
potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 3 | 2 | 6 |
Albumin | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 3 | 6 |
Translocator protein | 0 | 2 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 4 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 3 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
Luciferase | 8 | 0 | 0 | 8 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 5 | 0 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 1 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 5 | 0 | 5 |
Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 0 | 6 |
Substance-K receptor | 0 | 6 | 0 | 6 |
Sodium-dependent noradrenaline transporter | 0 | 8 | 1 | 9 |
Sodium-dependent serotonin transporter | 0 | 8 | 0 | 8 |
Vasopressin V1a receptor | 0 | 4 | 1 | 5 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Spike glycoprotein | 5 | 0 | 1 | 6 |
Estrogen-related receptor gamma | 0 | 1 | 1 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 1 | 0 | 2 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 3 | 0 | 3 |
Estrogen receptor beta | 1 | 8 | 5 | 14 |
Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 3 |
Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 2 | 5 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 2 | 5 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 5 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 4 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
Chain A, Cruzipain | 6 | 0 | 0 | 6 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
protein AF-9 isoform a | 0 | 0 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 0 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
Beta-3 adrenergic receptor | 0 | 4 | 0 | 4 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
Adenylate cyclase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
Coagulation factor XII | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 2 |
PPM1D protein | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
Vpr | 3 | 0 | 0 | 3 |
Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
Amyloid-beta precursor protein | 1 | 1 | 0 | 2 |
Thymidylate synthase | 0 | 4 | 0 | 4 |
Aromatase | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
Thymidylate synthase | 0 | 4 | 0 | 4 |
Dihydrofolate reductase | 0 | 2 | 3 | 5 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
Multidrug resistance associated protein | 0 | 1 | 0 | 3 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 3 | 0 | 3 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
fructose-bisphosphate aldolase A | 1 | 0 | 0 | 1 |
glyceraldehyde-3-phosphate dehydrogenase isoform 1 | 1 | 0 | 0 | 1 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Matrilysin | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
L-selectin | 0 | 1 | 0 | 1 |
P-selectin | 0 | 1 | 0 | 1 |
E-selectin | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
Autoinducer 2-binding periplasmic protein LuxP | 0 | 1 | 0 | 1 |
Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 2 |
Polypeptide N-acetylgalactosaminyltransferase 2 | 0 | 1 | 1 | 2 |
Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Toll-like receptor 2 | 0 | 1 | 0 | 1 |
Parkin | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor gamma | 0 | 1 | 0 | 1 |
Retinoic acid receptor beta | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-beta | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
Progesterone receptor | 0 | 5 | 2 | 9 |
Mineralocorticoid receptor | 1 | 3 | 1 | 6 |
Androgen receptor | 1 | 4 | 3 | 8 |
Androgen receptor | 0 | 0 | 1 | 1 |
Histamine H2 receptor | 0 | 4 | 0 | 4 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
ClpP | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 3 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
TSHR protein | 1 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
Cruzipain | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
Tegument protein VP16 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 1 | 1 | 3 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
Progesterone receptor | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 2 | 2 | 4 |
Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Chain A, CES1 protein | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 2 |
Procathepsin L | 0 | 0 | 1 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Protein kinase C iota type | 0 | 1 | 0 | 1 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 2 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |